Journal
Frontiers in Oncology
Publication Date
1-1-2022
Volume
12
First Page
856132
Document Type
Open Access Publication
DOI
10.3389/fonc.2022.856132
Rights and Permissions
Knapp B, Mezquita L, Devarakonda S, Aldea M, Waqar SN, Pepin K, Ward JP, Botticella A, Howarth K, Knape C, Morris C, Govindan R, Besse B and Morgensztern D (2022) Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer. Front. Oncol. 12:856132. doi: 10.3389/fonc.2022.856132 © 2022 Knapp, Mezquita, Devarakonda, Aldea, Waqar, Pepin, Ward, Botticella, Howarth, Knape, Morris, Govindan, Besse and Morgensztern. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Knapp, Brendan; Mezquita, Laura; Devarakonda, Siddhartha; Aldea, Mihaela; Waqar, Saiama N; Pepin, Kym; Ward, Jeffrey P; Botticella, Angela; Howarth, Karen; Knape, Charlene; Morris, Clive; Govindan, Ramaswamy; Besse, Benjamin; and Morgensztern, Daniel, "Exploring the feasibility of utilizing limited gene panel circulating tumor DNA clearance as a biomarker in patients with locally advanced non-small cell lung cancer." Frontiers in Oncology. 12, 856132 (2022).
https://digitalcommons.wustl.edu/oa_4/648
